ÂÜÀòÂÒÂ×

Kate Hermans has extensive experience in leadership positions across various sectors, particularly in healthcare and technology. Currently serving as Chair of Clue by Biowink and as a Board Member of Mid-Atlantic Diamond Ventures, Kate has demonstrated a commitment to reproductive health and supporting emerging technology-based companies. Previous roles include Non-Executive Director and Interim CEO at Ambrx, where strategic initiatives led to significant advancements, and Chief Business Officer at 83bar, focusing on patient activation through digital health. With a background that includes Vice President roles at Radius Health and Bristol-Myers Squibb, and senior positions at Pfizer, Kate has consistently driven growth and innovation. Kate's academic credentials include a Master of International Management from Thunderbird School of Global Management and a BA from Wheaton College.